Docetaxel Versus Cabazitaxel Post Abiraterone or Enzalutamide
Stopped The cabazitaxel was recently approved by the regulatory authorities for mCRPCa
Conditions
- Metastatic Prostate Cancer
Interventions
- DRUG: Cabazitaxel plus prednisone
- DRUG: Docetaxel plus prednisone
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborators